ATTO
Atento SA
NASDAQ · Healthcare · Biotechnology · US
$14.97
−1.96%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 506.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.06x
- Price / sales
- 506.22x
- Price / cash flow
- -11.54x
Enterprise value
- Enterprise value
- $830.8M
- EV / sales
- 615.42x
- EV / EBITDA
- -12.52x
- EV / EBIT
- -12.37x
- Market cap
- $683.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026